Clincosm LogoSign in Get a demo

NEUROFIN: Neuropsychology of Financial Capacity

Sponsor
Istituto Auxologico Italiano (Other)
Overall Status
Recruiting
CT.gov ID
NCT05791006
Collaborator
(none)
99
Enrollment
1
Location
39.9
Anticipated Duration (Months)
2.5
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The present project aims to investigate the financial capacity in patients diagnosed with Parkinson's Disease or parkinsonism, brain tumor (glioma or meningioma) and cerebrovascular lesion (stroke), in order to evaluate the presence and degree of impairment, and the role of some factors as potential predictors of financial incapacity.

The term 'financial capacity' means both operations relating, for example, to asset management or investing money, and activities of daily life such as shopping or using small sums of money; these activities are mediated by different cognitive functions, from numerical and arithmetic skills to decision making. Financial capacity is, in fact, an instrumental activity of daily life (i.e. Instrumental Activity Of Daily Living, I-ADL) whose impairment negatively affects the functional autonomy of the individual, so as to be subject to legal protection.

To assess financial capacity, the Numerical Activities of Daily Living - Financial (NADL-F; Arcara et al., 2017) will be administered, a battery of tests aimed at investigating both financial performance and financial competence according to the most recent neuropsychological models proposed in the literature.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Neuropsychological tests

Study Design

Study Type:
Observational
Anticipated Enrollment :
99 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Neuropsychology of Financial Capacity
Actual Study Start Date :
Aug 4, 2021
Anticipated Primary Completion Date :
Nov 30, 2024
Anticipated Study Completion Date :
Nov 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Patients with Parkinson's Disease/Parkinsonisms

Behavioral: Neuropsychological tests
Neuropsychological assessment with: NADL-F Frontal Assessment Battery (FAB) functional scales assessing activities of daily living (ADL) and instrumental activities of daily living (I-ADL) Mini-Mental Parkinson (MMP) - For Parkinson's Disease patients Montreal Cognitive Assessment (MoCA) - for brain tumor and stroke patients
Patients with brain tumors

Behavioral: Neuropsychological tests
Neuropsychological assessment with: NADL-F Frontal Assessment Battery (FAB) functional scales assessing activities of daily living (ADL) and instrumental activities of daily living (I-ADL) Mini-Mental Parkinson (MMP) - For Parkinson's Disease patients Montreal Cognitive Assessment (MoCA) - for brain tumor and stroke patients
Patients with ischemic or haemorrhagic stroke

Behavioral: Neuropsychological tests
Neuropsychological assessment with: NADL-F Frontal Assessment Battery (FAB) functional scales assessing activities of daily living (ADL) and instrumental activities of daily living (I-ADL) Mini-Mental Parkinson (MMP) - For Parkinson's Disease patients Montreal Cognitive Assessment (MoCA) - for brain tumor and stroke patients
Healthy Controls

Behavioral: Neuropsychological tests
Neuropsychological assessment with: NADL-F Frontal Assessment Battery (FAB) functional scales assessing activities of daily living (ADL) and instrumental activities of daily living (I-ADL) Mini-Mental Parkinson (MMP) - For Parkinson's Disease patients Montreal Cognitive Assessment (MoCA) - for brain tumor and stroke patients

Outcome Measures

Primary Outcome Measures

  1. Numerical Activity of Daily Living Financial (NADL-F) in Patients with Parkinson's Disease/Parkinsonisms [At baseline]

    Assessment of financial capacity; score range=0-62; higher scores indicate higher financial capacities

  2. Numerical Activity of Daily Living Financial (NADL-F) in Patients with ischemic or haemorrhagic stroke [At baseline]

    Assessment of financial capacity; score range=0-62; higher scores indicate higher financial capacities

  3. Change from baseline in Numerical Activity of Daily Living - Financial (NADL-F)Patients with brain tumors [At 3 and 12 months follow up]

    Assessment of financial capacity; score range=0-62; higher scores indicate higher financial capacities

  4. Montreal Cognitive Assessment (MoCA) [At baseline]

    Assessment of global cognitive functioning

  5. Frontal Assessment Battery (FAB) [At baseline]

    Assessment of global cognitive functioning

  6. Activities of daily living questionnaire (ADL) [At baseline]

    Assessment of function independence in everyday life

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 99 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

  • age > 18 years

  • Clinical diagnosis of interest for clinical groups

  • For stroke patients: disease duration > 1 month

Exclusion Criteria:

  • Other brain disorders different from those of interest

  • Sensory-motor deficits that could prevent neuropsychological assessment

  • Language disorders that could prevent neuropsychological assessment

  • Global cognitive impairment as indexed by MoCA < 26 or MMP < 22.85

Contacts and Locations

Locations

Site City State Country Postal Code
1 Istituto Auxologico Italiano IRCCS Milan Lombardia Italy 20122

Sponsors and Collaborators

  • Istituto Auxologico Italiano

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Istituto Auxologico Italiano
ClinicalTrials.gov Identifier:
NCT05791006
Other Study ID Numbers:
  • 25C121
First Posted:
Mar 30, 2023
Last Update Posted:
Mar 30, 2023
Last Verified:
Mar 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:
Parkinson Disease

Study Results

No Results Posted as of Mar 30, 2023